कृपया अन्य खोज का प्रयास करें
Imagion Biosystems Limited provides medical imaging technologies based on superparamagnetic relaxometry for cancer and disease detection, and monitoring therapy. It has activities in nanotechnology; biotechnology; cancer diagnostics; and superparamagnetic relaxometry. The company develops MagSense, which is in Phase I clinical trials for the treatment of HER2 breast cancers; and PrecisionMRX, an iron oxide nanoparticle to detect cancer. Imagion Biosystems Limited has a collaborative research program with Patrys Limited to use the combined technologies for enhancing brain tumor imaging and diagnosis; and a joint development agreement with Global Cancer Technology, Inc. to develop GCT’s novel nanoscintillator technology for the treatment of breast cancer. The company was incorporated in 2016 and is based in San Diego, California.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Michael John Harsh | 70 | 2017 | Non-Executive Director |
Mark Gerland Van Asten | - | 2016 | Non Executive Director |
John Hazle | - | 2018 | Chairman of Scientific Advisory Board |
David Gerald Ludvigson | 73 | 2017 | Non Executive Director |
Robert Ivkov | - | 2019 | Member of Scientific Advisory Board |
Jovanka Naumoska | - | 2016 | Non Executive Director |
Paul C. Grint | 66 | 2019 | Member of Scientific Advisory Board |
Andrew M. Scott | - | 2019 | Member of Scientific Advisory Board |
Dianne M. Angus | 64 | 2020 | Non-Executive Director |
Lisa Horvath | - | 2019 | Member of Scientific Advisory Board |
Robert Romeo Proulx | 66 | 2015 | Executive Chairman |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है